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Peritubular myoid cells, which form the walls of seminiferous tubules in the testis, are functionally 
unexplored. While they transport sperm and contribute to the spermatogonial stem cell niche, 
specifically their emerging role in the immune surveillance of the testis and in male infertility remains 
to be studied. Recently, cytokine production and activation of Toll-like receptors (TLRs) were uncovered 
in cultured peritubular cells. We now show that human peritubular cells express purinergic receptors 
P2RX4 and P2RX7, which are functionally linked to TLRs, with P2RX4 being the prevalent ATP-gated 
ion channel. Subsequent ATP treatment of cultured peritubular cells resulted in up-regulated (pro-)
inflammatory cytokine expression and secretion, while characteristic peritubular proteins, that is 
smooth muscle cell markers and extracellular matrix molecules, decreased. These findings indicate 
that extracellular ATP may act as danger molecule on peritubular cells, able to promote inflammatory 
responses in the testicular environment.
Male infertility is common and in a considerable number of cases the underlying causes are not known1,2. In 
infertile men, impairments of spermatogenesis are typically paralleled by alterations of testicular morphology. 
Common changes include fibrotic thickening of the tubular wall, and accumulation of macrophages and mast 
cells in both the testicular interstitial area and the tubular wall3–6. These alterations point to a form of sterile 
inflammation in the testes, specifically prevalent in the tubular wall, which is formed by peritubular cells and 
extracellular matrix (ECM).
Peritubular myoid cells are smooth muscle-like cells known for their contractile abilities that are of utmost 
importance for sperm transport7,8. Previous studies, including proteomic and secretomic analyses, revealed 
that these human testicular peritubular cells (HTPCs) secrete ECM components and act as paracrine signalling 
cells9. Intriguingly, they also secrete immunoregulatory factors10. Recently, Toll-like receptors (TLRs) as func-
tional key regulators of innate immune responses were identified in HTPCs11. It became evident that ligands 
like Pam3CysSerLys4 (PAM) or lipopolysaccharide (LPS) are able to activate TLR2/4 on peritubular cells. In 
addition, TLR2/4 was also targeted by the small ECM molecule biglycan in the same way as previously found in 
macrophages12. Biglycan-induced TLR signalling triggered an immune response including pro-inflammatory 
cytokine production and secretion13,14.
In this context, simultaneous activation of TLR2/4 and the purinergic receptor isoforms P2RX4 and P2RX7 
by biglycan has been discovered15. Both, P2RX4 and P2RX7, represent members of a family of ligand-gated ion 
channels that are activated by ATP at either relatively low (P2X4; EC50~1–10 µM) or substantially increased 
(P2X7; EC50~100–300 µM) concentrations16. In the testis, potential origins of extracellular ATP are infiltrating 
immune cells like mast cells and macrophages, as well as Sertoli cells17,18. Both cell types reside in the immediate 
vicinity of peritubular cells3,19,20. Thus, we hypothesized that ATP may act as a danger molecule in the testes in the 
context of sterile inflammation and may promote inflammatory responses in HTPCs. We explored this possibility 
in a human-focused approach.
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Results
Peritubular cells express the purinergic receptors P2RX4 and P2RX7. Expression of purinoceptor 
subtypes P2RX4 and P2RX7 in cultured HTPCs of different patients was demonstrated on both, transcript and 
protein level (Fig. 1a,b). All individual donor-derived cells expressed typical smooth muscle cell marker tran-
scripts ACTA2 (Actin, aortic smooth muscle) and calponin (CNN1)5,6,21, but lacked expression of the mast cell 
marker tryptase (TPSAB1, Fig. 1a)3. HTPC cultures were additionally analysed by CNN1 immunofluorescence 
staining (Supplementary Fig. 1) to confirm marker expression and purity of the cultured cells. Basal P2RX4 and 
P2RX7 receptor mRNA expression levels, but also ACTA2 expression levels varied between cultured cells from 
individual patients (Fig. 1c). In human testicular sections (Fig. 1d) P2RX4 was detected in peritubular cells, but 
also in germ cells and in the interstitial tissue by immunohistochemistry. P2RX7 expression in the human tes-
tis was confined to peritubular cells and endothelial cells of blood vessels (not shown). Staining of consecutive 
sections showed that immunoreactive peritubular cells expressed smooth muscle actin (SMA) and CNN1. In 
fibrotically thickened walls of seminiferous tubules, in which impairment of spermatogenesis was evident, P2RX4 
and P2RX7 were readily observed (Supplementary Fig. 2a,b). The presence of mast cells as a possible source of 
extracellular ATP in the immediate vicinity of the tubular wall, and therefore to the purinoceptors, was confirmed 
(Supplementary Fig. 2c–f).
HTPCs are sensitive to purinergic stimulation in vitro. To address whether HTPCs could be part of a 
paracrine purinergic signalling network22, we performed whole-cell patch-clamp recordings from cultured cells 
Figure 1. Expression of purinoceptors P2RX4 and P2RX7 in peritubular cells. (a) Expression of P2RX4 
and P2RX7 mRNA was revealed in HTPCs stemming from four individual patients (1–4) and in the human 
testis (+). Patient-derived HTPCs were additionally screened for the presence of smooth muscle cell markers 
ACTA2 and CNN1 and absence of the mast cell marker TPSAB1. Negative controls: non-reverse transcription 
control (−RT), non-template control (−). (b) Immunoblotting confirmed P2RX4 and P2RX7 expression in 
HTPCs from three different patients (a–c). Note that gel/blot images were cropped and full-length gels/blots 
are presented in Supplementary Fig. 5. (c) Basal P2RX4 (n = 8) and P2RX7 (n = 8/6) receptor mRNA levels 
at 6 h and 24 h varied between cells derived from individual patients, but also ACTA2 levels (n = 8) did not 
remain constant. Data are geometric mean with 95% confidence interval. (d) P2RX4 expression was detected in 
peritubular cells, germ cells and interstitial tissue, while P2RX7 expression was found in peritubular cells and 
vessels (not shown) solely. P2RX4 expression in the tubular wall overlapped with SMA and CNN1 expression 
and absence of tryptase staining in consecutive sections. Insets: Negative controls (pre-adsorption for P2RX4, 
omission of primary antibody for P2RX7); Bars = 20 µm.
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(Fig. 2a). HTPCs exhibited an average membrane capacitance (Cmem) of 27.5 ± 8.3 pF. When cells were exposed to 
ATP (10–1,000 µM) at a negative holding potential (Vhold = −80 mV), we consistently recorded a fast-activating 
inward current (IATP) in 47.5% of all HTPCs, whereas no such current was recorded in a similarly large frac-
tion of cells (52.5%; Fig. 2bi-ii). Upon prolonged exposure (5 s), the current saturated and then monotonically 
declined in presence of the stimulus (Fig. 2bi). Next, we asked whether ATP sensitivity is dose-dependent. At 
increasing extracellular ATP concentrations ([ATP]ex) of 10, 100 and 1,000 µM, HTPCs exhibited dose-dependent 
IATP amplitudes with apparent saturation at [ATP]ex ≥ 100 µM (Fig. 2c). In sharp contrast to previous observa-
tions in mouse spermatogonia23, the relatively small, desensitizing inward currents initiated by lower [ATP]ex 
(10–100 µM) did not change in amplitude, kinetics or desensitization rate upon exposure to high stimulus con-
centrations (1,000 µM). To examine the current–voltage relationship of IATP, we measured I–V curves at a rate 
of 2 Hz before, during and after stimulation with saturating [ATP]ex (100 µM; Fig. 2d–f). Currents reversed at 
approximately 0 mV and exhibited substantial inward rectification (Fig. 2d–f). The above properties all indicate 
that P2RX7 does not serve as the predominant ATP receptor in HTPCs24–26. Rather, our data suggest that cultured 
HTPCs express one or more purinergic receptor isoform(s) characterized by relatively high ATP sensitivity.
HTPC purinergic signals are likely mediated by P2RX4 receptors. To increase throughput, we next 
opted to analyse ATP sensitivity using ratiometric Ca2+ imaging of HTPC populations. For recording of cytosolic 
Ca2+ concentrations [Ca2+]c, HTPCs were loaded with fura-2/AM and briefly (3 s) exposed to increasing doses of 
ATP (0.1–1,000 µM; Fig. 3a). In many cells (33.5%), ATP stimulation triggered an immediate and robust [Ca2+]c 
signal that decayed after stimulus cessation (Fig. 3b). It is likely that the size of this responsive population is an 
underestimate since many of the remaining HTPCs (66.5%) were precluded from analysis because of spontaneous 
activity (see Material and Methods). When both peak [Ca2+]c signals (Fig. 3c) and response frequencies (Fig. 3d) 
were plotted as a function of stimulus concentration, ATP consistently induced dose-dependent responses with a 
shared activation threshold of ~3 µM. The linear dynamic range of the dose-response curves (Fig. 3c,d) spanned 
~2 logarithmic units (EC50 = 41 µM) and Ca2+ signals saturated at ~300 µM [ATP]. Since P2RX7, compared to 
other family members, exhibits substantially reduced ATP sensitivity [EC50 ≥ 300 µM]25,27,28, these results also 
point to expression of purinoceptor isoform(s) that display high ATP sensitivity.
Next, we sought to identify the involved P2X receptor isoforms by pharmacological fingerprinting of 
ATP-induced [Ca2+]c signals (Fig. 4). First, HTPCs were exposed repeatedly to saturating ATP concentrations 
(1,000 µM) in presence of standard (1 mM; S1) versus reduced (165 nM; S2) free extracellular [Ca2+]. Notably, we 
never observed ATP-induced [Ca2+]c elevations when extracellular [Ca2+] was reduced (Fig. 4a,e). This finding 
shows that, first, Ca2+ influx from the extracellular medium is necessary for ATP-mediated responses and that, 
second, P2Y receptor-dependent depletion of intracellular stores does not serve a primary function in HTPC 
purinergic signalling. Next, stimulations were carried out in presence of the selective P2RX7 receptor antagonist 
A438079 (10 µM), which blocks human P2RX7 at nanomolar concentrations26 but, in HTPCs, failed to affect 
ATP-mediated signals (Fig. 4b,e).
In a third series of pharmacological tests, HTPCs were exposed to a non-saturating ATP concentra-
tion (30 µM) in presence of different concentrations of either PPADS (Pyridoxal phosphate-6-azo(benzene-2
,4-disulfonic acid); Fig. 4c,e) or TNP-ATP (2′,3′-O-(2,4,6-Trinitrophenyl)adenosine-5′-triphosphate; Fig. 4d,e). 
Both agents are partially selective P2X receptor antagonists that inhibit human P2RX isoforms with variable 
efficacy. In HTPCs, ATP-induced [Ca2+]c signals were clearly affected by PPADS (1 µM) and essentially abolished 
by exposure to high drug concentrations (100 µM; Fig. 4c,e). By contrast, only elevated TNP-ATP concentrations 
(10 µM) significantly diminished ATP-mediated responses (Fig. 4d,e). Human P2RX1–3 and P2RX5 are blocked 
by nanomolar concentrations of both PPADS and TNP-ATP29. By contrast, human P2RX4 is considerably less 
sensitive to both drugs, displaying IC50 values in the mid-micromolar range29,30. Together, our pharmacological 
data are thus most consistent with functional expression of homomeric P2RX4 receptors in cultured HTPCs. This 
interpretation is further supported by the electrophysiological signature (desensitization with time constants of 
up to several seconds; pronounced inward rectification) and sensitivity (saturation at [ATP]ex ≥ 100 µM) of IATP 
(Fig. 2).
ATP mediates changes of peritubular cell characteristics and fosters up-regulation of inflammatory 
molecules. HTPCs are smooth muscle-like cells, which also secrete extracellular matrix, contribute to the 
spermatogonial stem cell niche and exhibit immunoregulatory functions6. To assess the impact of ATP on these 
characteristic features of HTPCs, three different strategies were applied: evaluation of changes in transcript levels, 
regulation of secreted cytokines in the supernatant and a whole cell proteomic approach. Cell viability during 
treatment was monitored via cell number and confluence determination in a live cell imaging system and addi-
tionally by cytotoxicity measurement via lactate dehydrogenase (LDH) release. Results revealed that cellular via-
bility was not negatively influenced by ATP (Supplementary Fig. 3).
ATP treatment resulted in a distinct decrease of purinoceptor mRNA expression after 6 h and 24 h (Fig. 5a). 
Characteristic smooth muscle cell markers (ACTA2, CNN1) were similarly decreased (Fig. 5b). ATP affected 
stem-cell niche regulatory factors (CXCL12, GDNF) only marginally, but in a time-dependent fashion (Fig. 5c). 
However, a panel of inflammation-associated genes showed moderately (IL6, IL33, CCL2) to substantially (IL1B, 
CCL7; Fig. 5d) increased expression. Yet, there was a different time-dependence in the mRNA elevation. While 
most transcript levels rose until 24 h, IL6 clearly reached a peak before 24 h. These changes suggest that ATP 
induces a switch from the smooth muscle cell-like phenotype and towards an immune-regulatory phenotype as it 
has been observed in vascular smooth muscle cells31.
Cytokine profiling of ATP-treated supernatants further revealed purinergic regulation of cytokine secretion 
in HTPCs (Fig. 6a,c). Firstly, we analysed those cytokines previously observed on transcript level. IL1B and IL33 
signals were below detection limit and IL6 and CCL2 were only marginally up-regulated. In comparison, levels 
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of the immunosuppressive cytokines, e.g. IL3, IL4 or IL10, were not affected (not shown). By contrast, CCL7 
abundance appeared numerically increased in treated HTPCs. In addition, we identified another factor, CXCL5, 
with elevated expression after ATP treatment, yet this increase did not reach statistical significance (Fig. 6a). 
CXCL5 mRNA expression levels in ATP-treated samples were however statistically significantly augmented at 
24 h (Fig. 6b). Among secreted proteins with reduced abundance after ATP treatment three previously unex-
pected candidates were determined: insulin-like growth factor-binding protein 3 (IGFBP3), osteopontin (SPP1) 
and thrombospondin 1 (THBS1), although only the first mentioned two factors were statistically significantly 
decreased (Fig. 6c). Here, concomitant detection of mRNA decrease reinforced our findings except for IGFBP3 
(Fig. 6d).
The third method, mass spectrometry of whole cell pellets, identified 83 in abundance affected candidate pro-
teins (p-value < 0.05; log2-fold change > |0.6|, Supplementary Table 1) in ATP-treated HTPCs (n = 6, 48 h), 38 
were reduced in abundance and 45 were increased in abundance. All proteins that were quantified (3533 proteins, 
Figure 2. Extracellular ATP stimulates HTPCs. (a) Phase-contrast micrograph depicting cultured HTPCs. A 
single cell is targeted by a patch pipette. (bi) Original current traces from representative whole-cell patch-clamp 
recordings (Vhold = −40 mV; S1, S4) from cultured HTPC challenged with ATP at increasing concentrations 
(10, 1,000 µM) and exposure durations (1 s, left and middle; 5 s right). Note that prolonged stimulation clearly 
revealed current desensitization. For clarity, currents were smoothed according to a ‘box 7’ algorithm (Igor Pro 
software) (bii) Bar graph quantifying the percentage of ATP-sensitive HTPCs. (c) Quantification of recordings as 
shown in (b). Bar chart depicting peak current amplitude measurements (mean ± SEM) in response to variable 
[ATP]ex (10, 100 and 1,000 µM). Numbers of experiments are indicated above bars. (d) Average maximal I–V 
curve (black trace) in response to 100 µM ATP (n = 4). Grey shadows indicate SEM. Inset shows mean currents 
at −80 mV and +80 mV, revealing substantial inward rectification. Representative current–voltage relationships 
(e) and current time course (f) in response to 100 µM ATP. Inset (e): Command voltage ramp, repeated at 
2 Hz. (f) Representative plots of current measurements at −80 mV (black dots) and +80 mV (empty circles), 
respectively, over time. When challenged with 100 µM ATP, a fast, but relatively small inward current develops 
and shows a transient peak followed by apparent desensitization.
www.nature.com/scientificreports/
5SCIenTIFIC REPORTS |  (2018) 8:1431  | DOI:10.1038/s41598-018-19624-3
identification with two individual peptides, false discovery rate (FDR) <1%) are listed in Supplementary Table 1. 
Interaction annotation revealed clustering between proteins of decreased abundance (Fig. 6e, PPI enrichment 
p-value 2.61e−11), but not among those of increased abundance. For instance, six KEGG pathways were signifi-
cantly enriched, the most prominent being ECM-receptor interaction (8 proteins, FDR 8.04e−10). Enriched GO 
terms were mostly related to collagen metabolism and ECM organization as well (Supplementary Table 1). To cor-
roborate this finding, transcript abundances of several of the clustering proteins were compared in ATP-treated 
versus untreated HTPCs (Fig. 6f). Significant decreases in collagens COL1A1, COL1A2, COL3A1, COL4A2, 
COL6A2 and lysyl oxidase (LOX) mRNA after 6 h corresponded to the results of the proteomic study.
All three approaches yielded different, but yet consistent results. Elevated cytokine production and secretion 
in response to ATP reinforce the proposition of ATP as a danger molecule able to promote (pro-)inflammatory 
processes in HTPCs. Meanwhile smooth muscle-like cell markers and ECM-secretive properties of the HTPCs 
were negatively influenced.
Discussion
Extracellular ATP serves as a danger molecule in a variety of tissues32, but its role in the human testis in health 
and disease has been poorly examined. To explore its actions in the testicular environment of men we turned to 
HTPCs, to date the sole human testicular cell culture model available, which provides the possibility of mecha-
nistic studies6. We applied complementary approaches and found that ATP can evoke distinct changes in HTPCs, 
which can foster inflammation. Therefore elevated levels of testicular ATP may contribute to male infertility.
Figure 3. ATP-dependent Ca2+ mobilization in HTPCs. (a and b) HTPC [Ca2+]c signals in response to 
increasing ATP concentrations (30, 300 and 1,000 µM; 1 s) were monitored by ratiometric fluorescence imaging 
in fura-2/AM-loaded cells. (a) Pseudocolour single frame images illustrate relative [Ca2+]c at different time 
points (rainbow 256 colourmap; blue = low Ca2+/red = high Ca2+). (b) Original traces depict the integrated 
fluorescence ratio f340/f380 of representative cells in user-defined regions of interest (ROIs; colour as in (a)) 
as a function of time. Note the discontinuous ordinate (//). (c and d) Average dose-response (c) and dose-
‘recruitment’ (d) curves depict peak elevations in [Ca2+]c (c) and the percentage of responsive HTPCs (d) upon 
exposure to increasing ATP concentrations, ranging from 0.1 µM to 1,000 µM. The threshold concentration 
for activation is ~3 µM, half-maximal activation/recruitment (EC50) is observed at 41 µM (c) and 15 µM (d), 
respectively, and saturated signals are induced by ATP concentrations of ≥300 µM. Sigmoid dose-response 
curves were calculated using the Hill equation. Individual data points in (c) show means ± SEM (n = 36–158).
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In the testis, extracellular ATP can originate from different sources, including Sertoli cells33 and activated 
immune cells18,34. Strikingly increased numbers of activated mast cells have previously been reported in testes of 
infertile patients, specifically in the peritubular compartment3,20. We confirmed and correlated this finding with the 
expression of the purinergic receptors P2RX4 and P2RX7 in the tubular wall in vivo and in vitro. A recent study in 
the lung identified a link between increased extracellular ATP levels, P2RX7 expression and development of fibro-
sis35. Together, these findings may hint to a role of ATP in sterile inflammatory events associated with male infertility.
Notably, we observed inter-individual differences in P2X receptor expression. This variability may result from 
patient’s variety and lifestyle, which cannot be controlled for, but also from the extent of impaired testicular function. 
These fluctuations in expression levels may explain variations in ATP-induced gene expression and cytokine release.
Electrophysiological characteristics of cultured HTPCs stemming from two different men pointed to P2RX4 
as the prevalent purinergic receptor compared to P2RX7. Measurements of intracellular [Ca2+] changes sup-
ported the hypothesis of a P2RX-mediated effect since ATP-induced Ca2+ signals depended on the presence 
of extracellular Ca2+. Both a specific P2RX7 antagonists and a high affinity blocker for P2RX1–3 and P2RX5 
failed to substantially inhibit ATP-dependent [Ca2+] elevations, whereas micromolar concentrations of PPADS 
dose-dependently blocked such signals. Consistent with the electrophysiological properties IATP in HTPCs, our 
findings suggest predominant functional expression of P2RX4. However, co-assembly and co-activation with 
P2RX7 cannot be excluded36,37 and require future investigation.
To date, peritubular cells have primarily been characterized by the expression of smooth muscle cell mark-
ers21,38 and loss of contractile markers has been associated with infertility39. Hence, ATP-mediated ACTA2 and 
CNN1 decreases in HTPCs could be first steps en route to infertility.
Figure 4. Pharmacological signature of ATP-dependent HTPC Ca2+ signals. (a–d) Representative original 
traces (f340/f380 versus time) of [Ca2+]c transients recorded from individual HTPCs challenged with ATP 
(1000 µM (a,b); 30 µM (c,d); 5 s; arrows) under control conditions and during different biophysical/
pharmacological treatments. Signals are abolished in absence of external Ca2+ (a), essentially unaffected by 
the P2RX7 receptor antagonist A438079 (10 µM (b)), and strongly or partly reduced in presence of PPADS 
(c) or TNP-ATP (d), respectively. Treatment duration (pre-incubation) is indicated by horizontal bars. (e) 
Bar chart quantifying the effects of different conditions on [Ca2+]c response amplitudes (black bars). Data 
are means ± SEM, normalized to control conditions (i.e., prior stimulation; white bars). Numbers of cells are 
indicated above bars. Asterisks (*) denote statistical significance, p < 0.05 (paired t-test).
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CXCL1210,40 and GDNF9,41 are by HTPCs-produced and -secreted factors with importance for spermatogonial 
stem cell maintenance. Their mRNA levels were significantly, but not drastically altered by ATP treatment after 6 h 
and only marginally changed after 24 h. CXCL12 secretion (n = 4, p = 0.762; not shown) remained unchanged in 
response to ATP. Thus, ATP does not alter these contributions of HTPCs to the stem cell niche.
By contrast, prior studies of HTPCs revealed their ability to secrete immunoregulatory factors10. Recently, 
functional Toll-like receptors were identified in HTPCs and a danger signal from the ECM, biglycan, was impli-
cated in their activation, entailing secretion of the chemo-/cytokines CCL2 and IL611. ATP was also able to induce 
CCL2 and IL6 production and secretion in HTPCs, similar to results from other cell types42–45. However, IL6 
and CCL2 levels were only mildly elevated. In contrast, CCL7, a sister molecule of CCL2, exhibited a strong 
increase in response to ATP. A comparable result has previously been reported in murine mast cells46. IL1B is 
the prototypical pro-inflammatory cytokine and highly elevated by extracellular ATP in HTPCs and other cells 
e.g. via purinergic mechanisms47–49. Its family member IL33 is constitutively expressed by smooth muscle cells50 
and plays an important role during inflammation in diseases associated with tissue fibrosis51. CXCL5 is a novel 
player in ATP-mediated cytokine regulation, as it has mainly been known as a chemoattractant in neutrophil 
recruitment52. Yet, it has the ability to bind to the same receptor as CCL2 and CCL7 and may be jointly regu-
lated53,54. Together, ATP evoked an increase in (pro-)inflammatory and immunoregulatory gene expression and 
corresponding protein secretion in HTPCs.
All identified factors reduced in abundance by ATP are important components of the ECM55. While col-
lagens mainly form the ECM core structure, THBS1, SPP1 and IGFBP3 exhibit various interactive properties. 
THBS1 is able to bind to collagens and other ECM molecules, including biglycan, thereby modulating cell-matrix 
interactions56. SPP1 is expressed in numerous cell types including smooth muscle cells57 and is involved as 
pro-inflammatory factor in macrophage recruiting and cytokine secretion58. Moreover, THBS1 and SPP1 have 
been described to directly bind to IGFBP3 (albeit with lower affinity than to IGFBP5, which was not included in 
our secretion array)59. Increased IGFBP3, apart from its role in regulation of soluble insulin-like growth factor 
availability, can also induce elevated collagen production in smooth muscle cells60. This could imply the possibil-
ity of a collagen down-regulation upon a decrease in IGFBP3.
We are not aware of comparable in vitro studies examining ATP action on ECM in other human smooth mus-
cle cells, yet the result of ATP-induced ECM molecule decreases in HTPCs contrast in vivo findings from systemic 
studies of both the kidney and respiratory tract in mice61,62. It therefore remains to be determined whether and, if 
so, how the ATP/P2RX4 axis of peritubular cells may be related to testicular fibrotic ECM deposits in men suffer-
ing from infertility. Such ECM deposits could conceivably develop as a consequence of an overall inflammatory 
environment in vivo. Temporal aspects may also play a crucial role. Since in our study the mRNA decrease was 
observed mostly at 6 h, but was restored at 24 h, only a transient decline in ECM production may occur. Limited 
access to patient material prevented us from further investigation.
In summary, the experimental approaches delivered complementary results, which taken together provide 
mechanistic insights into the actions of ATP in the human testis. Specifically, elevated cytokine production and 
secretion in response to ATP reinforce the proposition of ATP acting via P2X receptors as a danger molecule able 
to promote (pro-)inflammatory processes in HTPCs.
Figure 5. ATP treatment affected characteristic peritubular markers and inflammation-associated genes. (a) 
After ATP treatment of HTPCs P2RX4 (n = 8) and P2RX7 (n = 8/6) mRNA levels were significantly down-
regulated. (b) mRNA levels of smooth muscle cell markers ACTA2 (n = 8) and CNN1 (n = 8) were significantly 
decreased by ATP treatment. (c) Stem cell niche regulatory factors CXCL12 (n = 8) and GDNF (n = 8/6) mRNAs 
were marginally influenced in a time-dependent manner. (d) Inflammation-associated genes IL1B (n = 8/5), IL6 
(n = 8), IL33 (n = 8), CCL2 (n = 8) and CCL7 (n = 8/6) mRNA levels were increased after ATP treatment. Data 
are means ± SEM after 6 h and 24 h, normalized to control conditions. Asterisks denote statistical significance, 
*p < 0.05, **p < 0.01, ***p < 0.001 (one-sample t-test).
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Material and Methods
Cell culture and treatment. HTPCs were isolated from human testicular tissue samples exhibiting normal 
spermatogenesis as described previously21,63. The patients (undergoing reconstructive surgery of the vas defer-
ens, 36–52 years old) had granted written Informed Consent for the scientific use of the cells. The local Ethical 
Committee (Ethikkommission, Technische Universität München, Fakultät für Medizin, München, project num-
ber 5158/11) has approved the study. All experiments were performed in accordance with relevant guidelines and 
regulations (including all laboratory and biosafety regulations). Cells were cultivated in DMEM High Glucose 
(Gibco, Paisley, UK) supplemented with 10% fetal bovine serum (FBS, Capricorn Scientific, Ebsdorfergrund, 
Germany) and 1% penicillin/streptomycin (Biochrom, Berlin, Germany) at 37 °C, 5% (v/v) CO2. For the experi-
ments defined cell numbers were seeded onto dishes or plates. 24 h prior to stimulation cells were serum starved. 
As agent for treatment ATP (1 mM, Sigma-Aldrich, Steinheim, Germany) was applied. Pilot studies were per-
formed to evaluate optimal time frames for treatment depending on the applied method. Transcript levels were 
measured 6 h and 24 h post stimulation, whereas mass spectrometry and cytokine profiling were performed 48 h 
post stimulation.
RT-PCR and qPCR. Total RNA from harvested cells was extracted using the RNeasy Plus Micro Kit 
(Qiagen, Hilden, Germany). Reverse transcription of 200 ng or 1 µg RNA was performed utilizing SuperScriptII 
Figure 6. ATP treatment influences cytokine secretion and ECM protein expression. (a) CXCL5 and CCL7 
levels were numerically, but not statistically significantly elevated after ATP treatment of HTPCs, whereas IL6 
and CCL2 levels were unaltered (n = 4 each). (b) At mRNA level, CXCL5 increased statistically significantly 
(n = 8/6). (c) ATP treated supernatants of HTPCs exhibited a statistically significant decrease in IGFBP3, SPP1 
and a numerical decrease in THBS1 (n = 4 each) protein levels. (d) Decrease of IGFBP3 (n = 8), SPP1 (n = 8/6) 
and THBS1 (n = 8) was recapitulated on mRNA level, yet only the later two reached statistical significance.  
(e) Down-regulated candidate proteins after ATP treatment clustered for enrichment in pathways or GO terms 
related to ECM organization and collagen metabolism. Collagens were the most highly abundant proteins 
within this subset. (f) ATP-induced decrease of collagens was confirmed by reduced mRNA levels of COL1A1, 
COL1A2, COL3A1, COL4A2, COL6A2 and LOX (n = 8 each) after 6 h, but not 24 h of treatment. Data are 
means ± SEM (protein: after 48 h; mRNA: after 6 h and 24 h), normalized to control conditions. Asterisks denote 
statistical significance, *p < 0.05, **p < 0.01, ***p < 0.001 (one-sample t-test).
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(Invitrogen, Darmstadt, Germany) and random 15mer primers. For qPCR studies the QuantiFast SYBR Green 
PCR Kit (Qiagen, Hilden, Germany) was applied using the primers depicted in Table 1 (designed using Primer3, 
http://primer3.wi.mit.edu, final concentration 300–900 nM) for amplification. Samples (final cDNA concentra-
tion 2 or 20 ng/reaction) were analysed in duplicates in a LightCycler® 96 System (Roche Diagnostics, Penzberg, 
Germany) under following conditions: Pre-incubation (95 °C, 5 min), 35–42 cycles of denaturation and anneal-
ing/extension (95 °C, 10 sec/annealing temperature see Table 1, 30 sec) followed by a melting step (continuous 
heating from 65 °C to 97 °C) and a cool-down (37 °C, 30 sec). Amplicon identity was confirmed via agarose gel 
electrophoresis and sequence analysis (GATC, Konstanz, Germany). Basal levels and therefore levels after treat-
ment between HTPCs from different patients varied as exemplified for IL1B in Supplementary Fig. 4a,b. Thus, 
analysis of results was performed according to the 2−ΔΔCq method64 and expression was normalized to RPL19 and 
HPRT as endogenous reference. Reference genes exhibited stable Cq values in all samples measured. The corre-
sponding boxplots and statistics are depicted in Supplementary Fig. 4c,d.
Immunoblotting. Whole cell lysates were generated and blotted as described previously11,19. The follow-
ing antibodies were used: Polyclonal rabbit anti-P2RX4 IgG (1:100, HPA039494, Atlas Antibodies, Stockholm, 
Sweden) and monoclonal rabbit anti-P2RX7 IgG (1:500, GTX62830, GeneTex/Biozol, Eching, Germany). For 
detection HRP-conjugated corresponding secondary antibodies and chemiluminescent solutions (SuperSignal® 
West Femto Maximum Sensitivity Substrate; Pierce, Thermo Scientific, Rockford, IL, USA) were applied.
Supernatant protein profiling. Supernatants of ATP-treated versus untreated cells were collected and 
analysed using the Proteome Profiler Human XL Cytokine Array Kit (R&D Systems, Minneapolis, MN, USA) 
according to the manufacturer’s instructions. Quantitative analysis of spot density was performed using Fiji65.
Immunohistochemistry. Immunohistochemical staining of paraffin-embedded human testicular tissue 
samples fixed by Bouin’s solution was performed as described previously11. They include samples from patients 
with mixed atrophy, in which tubules with normal spermatogenesis coexist with tubules bearing impaired sper-
matogenesis and a thickened wall. The local Ethical Committee (Ethikkommission, Technische Universität 
München, Fakultät für Medizin, München, project number 5158/11) has approved the study. Samples were 
sectioned at 5 µm thickness for immunostaining. The following antibodies were applied: Polyclonal rabbit 
anti-P2RX4 IgG (1:50, HPA039494, Atlas Antibodies, Stockholm, Sweden), polyclonal rabbit anti-P2RX7 IgG 
(1:50, HPA042013, Atlas Antibodies, Stockholm, Sweden), monoclonal mouse anti-Mast Cell Tryptase antibody 
(1:300, M7052, Dako, Carpinteria, CA, USA), monoclonal rabbit anti-Calponin-1 (1:250, 1806–1, Epitomics, 
Burlingame, CA, USA) and monoclonal mouse anti-Actin, α-Smooth Muscle antibody (1:2000, A5228, 
Sigma-Aldrich, St. Louis, MO, USA). Negative controls consisted of pre-adsorbed primary antibody for P2RX4 
and of omission of the primary antibody for P2RX7, SMA, CNN1 and tryptase or incubation with non-immune 
serum instead of the antibody. Sections were counterstained with hematoxylin.
Whole cell pellet proteome analysis. Cell lysis was performed with an ultrasonic device (10,000 kJ, 
Sonoplus GM3200 with BR30 cup booster, Bandelin, Berlin, Germany) in 7 µl 8 M urea/0.4 M NH4HCO3 per 
100,000 cells. Samples were further centrifuged through QIA-Shredder devices (Qiagen, Hilden, Germany). 
Protein concentrations were determined by a Bradford assay66 and the samples were adjusted with 8 M urea/0.4 M 
NH4HCO3 to a concentration of 2 mg/ml protein. Cysteine residues were reduced for 30 min using DTE at a 
concentration of 4.5 mM and blocked with iodoacetamide (final concentration 10 mM) for 30 min in the dark. 
Samples were diluted with water to a concentration of 1 M urea and trypsinised overnight at 37 °C using 20 ng 
porcine trypsin (Promega, Madison, WI, USA) per µg of protein. For LC-MS/MS analysis an Ultimate 3000 chro-
matography system (Thermo Scientific, Waltham, MA, USA) coupled to a TripleTOF 5600+ mass spectrometer 
(Sciex, Concord, Canada) was used. 2.5 µg of peptides diluted in 0.1% formic acid (FA) were injected on a trap 
column (Acclaim PepMap 100, μ-Precolumns, 5 mm × 300 μm, 5 μm particles, Thermo Scientific) and separated 
at a flow rate of 200 nL/min (Acclaim PepMap RSLC C18, 75 μm × 50 cm, 2 μm; Thermo Scientific). The LC 
method consisted of consecutive gradients from 5% to 25% solvent B (0.1% FA, 100% ACN) in 290 min and from 
25% to 50% solvent B in 30 min. MS spectra were acquired using a top 70 method (mass range m/z 400–1250, 
rolling collision energy activated). Peptide identification and LFQ quantification was performed with MaxQuant 
V1.5.167 using the Homo sapiens subset of the UniProt database. For identification, the MaxQuant default param-
eters for Sciex TOF instruments were used and the FDR at the peptide and protein level was set to 1%. Student’s 
t-test was performed with the Perseus module of MaxQuant. To handle missing values the Perseus imputation 
feature was used in cases where proteins were detected in at least three replicates of one group. Enrichment anal-
ysis was performed with the STRING analysis tool (http://string-db.org, version 10.0) using default options68.
Chemicals and solutions for (electro)physiological recordings. The following solutions were used:
(S1) 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES) buffered extracellular solution con-
taining (in mM) 145 NaCl, 5 KCl, 1 CaCl2, 0.5 MgCl2, 10 HEPES; pH = 7.3 (adjusted with NaOH); osmolar-
ity = 300 mOsm (adjusted with glucose).
(S2) Extracellular low Ca2+ solution containing (in mM) 145 NaCl, 5 KCl, 1.5 CaCl2, 0.62 MgCl2, 10 HEPES, 
2.37 EGTA; pH = 7.3 (NaOH); osmolarity = 300 mOsm (glucose), [Ca2+]free = ~165 nM.
(S3) Standard pipette solution containing (in mM) 143 KCl, ~2 KOH, 1 EGTA, 0.3 CaCl2, 10 HEPES, 1 
Na-GTP ([Ca2+]free = 120 nM); pH = 7.1 (adjusted with KOH); osmolarity = 290 mOsm (glucose).
(S4) Cs+-based pipette solution containing (in mM) 143 CsCl, ~2 CsOH, 1 EGTA, 0.3 CaCl2, 10 HEPES, 1 
Na-GTP ([Ca2+]free = 120 nM); pH = 7.1 (adjusted with CsOH); osmolarity = 290 mOsm (glucose).
www.nature.com/scientificreports/
1 0SCIenTIFIC REPORTS |  (2018) 8:1431  | DOI:10.1038/s41598-018-19624-3
Free Ca2+ concentrations were calculated using WEBMAXC (http://web.stanford.edu/~cpatton/web-
maxcE.htm). If not stated otherwise, chemicals were purchased from Sigma (Schnelldorf, Germany). Pyridoxal 
phosphate-6-azo(benzene-2,4-disulfonic acid) tetrasodium salt hydrate (PPADS; cat. no. P178) was purchased 
from Sigma (Schnelldorf, Germany). 3-[[5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl]methyl]pyridine hydrochlo-
ride (A-438079; cat. no. 2972) was purchased from Tocris Bioscience (Bristol, UK). 2′,3′-O-(2,4,6-Trinitrophenyl)
adenosine-5′-triphosphate tetra(triethylammonium) salt (TNP-ATP; cat. no. BN0523) was purchased from 
BIOTREND (Cologne, Germany). Final solvent concentrations were ≤0.1%. When high ATP concentra-
tions (≥1 mM) were used, pH was readjusted. Solutions and pharmacological agents were applied from air 
pressure-driven reservoirs via an 8-in-1 multi-barrel ‘perfusion pencil’ (Science Products, Hofheim, Germany). 
Changes in focal superfusion69 were software-controlled and, if required, synchronized with data acquisition 
by TTL input to 12 V DC solenoid valves using a TIB 14 S digital output trigger interface (HEKA Elektronik, 
Lambrecht/Pfalz, Germany).
Electrophysiology. Cultured cells were transferred to the stage of an inverse microscope (DMI 4000B, 
Leica Microsystems, Wetzlar, Germany) equipped for phase contrast and infrared-optimized differential inter-
ference contrast (IR-DIC). Cells were observed using phase contrast objectives (HC PL FLUOTAR 10 × 0.3 
NA and HCX PL FL L 63 × 0.70 NA CORR PH2; Leica Microsystems). Images were recorded using a cooled 
CCD-camera (DFC360FX; Leica Microsystems). Patch pipettes (5–7 MΩ) were pulled from borosilicate glass 
capillaries (1.50 mm OD/1.05 mm ID; Science Products) on a PC-10 micropipette puller (Narishige Instruments, 
Tokyo, Japan), fire-polished (MF-830 Microforge; Narishige Instruments) and filled with pipette solution (S3 or S4 
depending on experimental design). An agar bridge (150 mM KCl) connected reference electrode and bath solu-
tion. An EPC-10 USB amplifier controlled by Patchmaster v2x90.1 software (HEKA Elektronik) was used for data 
acquisition. We monitored and compensated pipette and membrane capacitance (Cmem) as well as series resistance 
(Rseries = 16.0 ± 7.8 MΩ (mean ± SD)). Liquid junction potentials were calculated using JPCalcW software70 and 
corrected online. Signals were low-pass filtered [analog 3- and 4-pole Bessel filters (−3 dB); adjusted to1/4−1/5 
of the sampling rate (10 kHz; depending on protocol)]. If not stated otherwise, holding potential (Vhold) was −40 
mV. All data were recorded at RT. Voltage ramp protocols are described in the Results section.
Ca2+ imaging. HTPCs were grown on 30 mm glass-bottom dishes for 1 to 4 d and loaded with fura-2/AM 
(5 µM; 30 min; RT; S1). Dye-loaded cells were washed in S1 and transferred to the stage of an inverted micro-
scope (Leica DMI4000B; Leica Microsystems) equipped for ratiometric live-cell imaging with a 120 W mercury 
short-arc reflector lamp (Leica EL6000; Leica Microsystems), a motorized fast-change filter wheel illumination 
system for multi-wavelength excitation (Leica Microsystems), a 12 bit 1376 × 1032 pixel cooled monochrome 
CCD camera (DFC 360FX; Leica Microsystems), and LASAF 2.4 imaging software (Leica Microsystems). 4–60 
Gene Reference ID Nucleotide sequence
Amplicon 
size
Annealing 
temperature
ACTA2 NM_001613.2 5′-ACA ATG AGC TTC GTG TTG CC-3′ 5′-GAG TCA TTT TCT CCC GGT TGG-3′ 90 bp 59 °C
CCL2 NM_002982.3 5′-CAG CCA GAT GCA ATC AAT GCC-3′ 5′-TGG AAT CCT GAA CCC ACT TCT-3′ 190 bp 58 °C
CCL7 NM_006273.3 5′-TGG AGA GCT ACA GAA GGA CCA-3′ 5′-GTG GGG TCA GCA CAG ATC TC-3′ 94 bp 58 °C
CNN1 NM_001299.5 5′-CGA AGA CGA AAG GAA ACA AGG T-3′ 5′-GCT TGG GGT CGT AGA GGT G-3′ 186 bp 62 °C
COL1A1 NM_000088.3 5′-AAG AGG AAG GCC AAG TCG AG-3′ 5′-CAC ACG TCT CGG TCA TGG TA-3′ 91 bp 60 °C
COL1A2 NM_000089.3 5′-CCG GAG ATA GAG GAC CAC GT-3′ 5′-CAG CAA AGT TCC CAC CGA GA-3′ 132 bp 60 °C
COL3A1 NM_000090.3 5′-GGT GGT TTT CAG TTT AGC TAC GG-3′ 5′-TGA TGT TCT GGG AAG CTC GG-3′ 106 bp 59 °C
COL4A2 NM_001846.3 5′-AAG GAA TCA TGG GCT TTC CT-3′ 5′-CTC TGG CAC CTT TTG CTA GG-3′ 204 bp 60 °C
COL6A2 NM_001849.3 5′-GTC ATG AAA CAC GAA GCC TAC G-3′ 5′-CAC CCT TCT GTC CAC GGT AG-3′ 97 bp 59 °C
CXCL12 NM_000609.6 5′-TCA GCC TGA GCT ACA GAT GC-3′ 5′-CTT TAG CTT CGG GTC AAT GC-3′ 161 bp 60 °C
CXCL5 NM_002994.4 5′-CAG CGC TCT CTT GAC CAC TA-3′ 5′-GAA CTC CTT GCG TGG TCT GT-3′ 194 bp 60 °C
GDNF NM_000514.3 5′-GCA GAC CCA TCG CCT TTG AT-3′ 5′-ATC CAC ACC TTT TAG CGG AAT G-3′ 93 bp 60 °C
HPRT NM_000194.2 5′-CCT GGC GTC GTG ATT AGT GA-3′ 5′-GGC CTC CCA TCT CCT TCA TC-3′ 163 bp 60 °C
IGFBP3 NM_001013398.1 5′-ACA GCC AGC GCT ACA AAG TT-3′ 5′-CTA CGG CAG GGA CCA TAT TC-3' 100 bp 59 °C
IL1B NM_000576.2 5′-CTT GGT GAT GTC TGG TCC ATA TG-3′ 5′-GGC CAC AGG TAT TTT GTC ATT AC-3′ 127 bp 60 °C
IL33 NM_001199641.1 5′-AGG TGA CGG TGT TGA TGG TAA-3′ 5′-AAG GAC AAA GAA GGC CTG GT-3′ 142 bp 60 °C
IL6 NM_000600.4 5′-AAC CTG AAC CTT CCA AAG ATG G-3′ 5′-TCT GGC TTG TTC CTC ACT ACT-3′ 159 bp 60 °C
LOX NM_001317073.1 5′-CAC ACA CAC AGG GAT TGA GTC-3′ 5′-AGT CAG ATT CAG GAA CCA GGT-3′ 147 bp 60 °C
P2RX4 NM_001256796.1 5′-AGA TGC GAC CAC TGT GTG TA-3′ 5′-GTT GAG ACT CCG TTG CTG TG-3′ 78 bp 60 °C
P2RX7 NM_002562.5 5′-TGT CCC ATT TTC CGA CTA GG-3′ 5′-CCA ACG GTC TAG GTT GCA GT-3′ 120 bp 60 °C
RPL19 NM_000981.3 5′-AGG CAC ATG GGC ATA GGT AA-3′ 5′-CCA TGA GAA TCC GCT TGT TT-3′ 199 bp 60 °C
SPP1 NM_001040058.1 5′-TTT TCA CTC CAG TTG TCC CC-3′ 5′-TAC TGG ATG TCA GGT CTG CG-3′ 109 bp 59 °C
THBS1 NM_003246.3 5′-AGT CGT CTC TGC AAC AAC CC-3′ 5′-AGC TAG TAC ACT TCA CGC CG-3′ 148 bp 60 °C
TPSAB1 NM_003294.3 5′-GCG ATG TGG ACA ATG ATG AG-3′ 5′-CAA GGT GGT ATT TTG CGT CA-3′ 102 bp 60 °C
Table 1. Oligonucleotide primer sequences and corresponding parameters for qPCR experiments.
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cells in randomly selected fields of view (890 µm × 665 µm) were illuminated sequentially at 340 nm and 387 nm 
(cycle time 3 s). The average pixel intensity within user-selected regions-of-interest (ROIs) was digitized and 
stored on a PC. Ca2+-dependent fluorescence signals at 510 nm were background-corrected, calculated as the 
f340/f380 intensity ratio, and displayed as a function of time. Categorization of HTPCs as ATP sensitive (Fig. 3) was 
based on standard criteria, i.e., responses were evaluated according to a ΔR(f340/f387) > 3 × SD R(baseline) criterion71. 
Notably, cells that exhibited spontaneous recurrent Ca2+ transients could not be unequivocally categorized and 
were therefore discarded. Thus, the percentage of ATP-sensitive HTPCs that we report here is likely to represent 
an underestimate.
Data analysis. Statistical analyses of qPCR and supernatant data were obtained using GraphPad Prism 6.0 
Software (GraphPad Software Inc., San Diego, CA, USA). qPCR data were analysed via a one-sample t-tests 
of −ΔΔCq values, as were cytokine levels in the supernatant via a one-sample t-tests of not normalized values. 
Electrophysiology and Ca2+ imaging data were obtained from independent experiments performed on at least 
two days with cells derived from two different patients. Individual numbers of cells/experiments (n) are denoted 
in the figure and/or captions. Data were analysed offline using FitMaster 2.9 (HEKA Elektronik), IGOR Pro 
6.4 (WaveMetrics, Lake Oswego, OR, USA) and Excel 2013 (15.0.4779.1001; Microsoft, Seattle, WA, USA) soft-
ware. Statistical analyses were performed using paired t-tests. If not stated otherwise, all results are presented as 
means ± SEM. Corresponding p-values that report statistical significance (≤0.05) are individually specified in 
the captions.
Data Availability. Data generated and analysed during this study are included in this published article and 
its Supplementary Information files. The original raw datasets generated during the current study are available 
from the corresponding author on reasonable request.
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